Clinical Trial Update: Effects of Pre-emptive Scalp Infiltration With Low-dose Ketorolac and Ropivacaine for Postoperative Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pre-emptive scalp infiltration with low-dose ketorolac and ropivacaine for postoperative pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Supratentorial Brain Tumor

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Pain, Supratentorial Brain Tumor | Phase 4 | Status: UNKNOWN